Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Science Immunology · 27.01.2023 · 8 (79)
DOI: 10.1126/sciimmunol.ade2798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 27.01.2023. Verfasst von Pascal Irrgang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institut für klinische und molekulare Virologie, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Schlossga…. Hauptthemen laut MEDLINE: COVID-19, Immunoglobulin G. Die Arbeit wurde bisher 264-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
RNA vaccines are efficient preventive measures to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 antibodies are an important component of vaccine-induced immunity. Shortly after the initial two mRNA vaccine doses, the immunoglobulin G (IgG) response mainly consists of the proinflammatory subclasses IgG1 and IgG3. Here, we report that several months after the second vaccination, SARS-CoV-2–specific antibodies were increasingly composed of noninflammatory IgG4, which were further boosted by a third mRNA vaccination and/or SARS-CoV-2 variant breakthrough infections. IgG4 antibodies among all spike-specific IgG antibodies rose, on average, from 0.04% shortly after the second vaccination to 19.27% late after the third vaccination. This induction of IgG4 antibodies was not observed after homologous or heterologous SARS-CoV-2 vaccination with adenoviral vectors. Single-cell sequencing and flow cytometry revealed substantial frequencies of IgG4-switched B cells within the spike-binding memory B cell population [median of 14.4%; interquartile range (IQR) of 6.7 to 18.1%] compared with the overall memory B cell repertoire (median of 1.3%; IQR of 0.9 to 2.2%) after three immunizations. This class switch was associated with a reduced capacity of the spike-specific antibodies to mediate antibody-dependent cellular phagocytosis and complement deposition. Because Fc-mediated effector functions are critical for antiviral immunity, these findings may have consequences for the choice and timing of vaccination regimens using mRNA vaccines, including future booster immunizations against SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut für klinische und molekulare Virologie, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Schlossgarten 4, 91054 Erlangen, Germany.
- Department of Biology, Division of Genetics, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
- Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Wasserturmstr. 3/5, 91054 Erlangen, Germany.
- Center of Structural and Cell Biology in Medicine, Institute of Biochemistry, University of Luebeck, Luebeck, Germany.
- Freiburg University Medical Center, Faculty of Medicine, Institute of Virology, University of Freiburg, Freiburg, Germany.
- Medical Immunology Campus Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Schlossplatz 1, 91054 Erlangen, Germany.
ORCID-Profile: Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Monika Wytopil, Jahn Zhong, George Ssebyatika, Thomas Krey, Valeria Falcone, Antonia Sophia Peter, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Zitieren
APA
Irrgang, P., Gerling, J., Kocher, K., Lapuente, D., Steininger, P., Habenicht, K., Wytopil, M., Beileke, S., Schäfer, S., Zhong, J., Ssebyatika, G., Krey, T., Falcone, V., Schülein, C., Peter, A. S., Nganou-Makamdop, K., Hengel, H., Held, J., Bogdan, C., …, & Tenbusch, M. (2023). Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science Immunology, 8(79). https://doi.org/10.1126/sciimmunol.ade2798
Vancouver
Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht K, et al. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science Immunology. 2023;8(79). doi:10.1126/sciimmunol.ade2798
BibTeX
@article{Irrgang2023,
author = {Irrgang, Pascal and Gerling, Juliane and Kocher, Katharina and Lapuente, Dennis and Steininger, Philipp and Habenicht, Katharina and Wytopil, Monika and Beileke, Stephanie and Schäfer, Simon and Zhong, Jahn and Ssebyatika, George and Krey, Thomas and Falcone, Valeria and Schülein, Christine and Peter, Antonia Sophia and Nganou-Makamdop, Krystelle and Hengel, Hartmut and Held, Jürgen and Bogdan, Christian and Überla, Klaus and Schober, Kilian and Winkler, Thomas H and Tenbusch, Matthias},
title = {Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination},
journal = {Science Immunology},
year = {2023},
volume = {8},
number = {79},
doi = {10.1126/sciimmunol.ade2798}
}
EUVIMED